Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia
- 1 May 2012
- journal article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 18 (5), E122-E127
- https://doi.org/10.1111/j.1469-0691.2012.03777.x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Persistence of a Positive (1,3)-β- d -Glucan Test after Clearance of Candidemia in Hematopoietic Stem Cell Transplant RecipientsClinical and Vaccine Immunology, 2011
- Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive AspergillosisJournal of Clinical Microbiology, 2010
- Serum (1→3) β‐d‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis ofPneumocystisPneumonia in Patients with AIDSClinical Infectious Diseases, 2009
- Surrogate and Mediating Endpoints: Current Status and Future DirectionsJNCI Journal of the National Cancer Institute, 2009
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus CriteriaClinical Infectious Diseases, 2008
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- Pseudomonas aeruginosaas a Cause of 1,3‐β‐d‐Glucan Assay ReactivityClinical Infectious Diseases, 2008
- 1,3- -D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute LeukemiaClinical Infectious Diseases, 2008
- Assessment of Serum (1→3)-β- d -Glucan Concentration as a Measure of Disease Burden in a Murine Model of Invasive Pulmonary AspergillosisAntimicrobial Agents and Chemotherapy, 2008
- Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1 → 3)-β-d-glucan, SSG, in miceFEMS Immunology & Medical Microbiology, 1996